The relationship between nut consumption and the risk of developing non-communicable diseases (NCDs) has been a subject of growing interest. However, the findings from previous studies have been conflicting for some health outcomes, such as type-2 diabetes, and have been underexplored for other outcomes, such as neurodegenerative diseases. One contributing factor to these inconsistencies lies in the different analytical approaches and confounding factors used across studies. Furthermore, the majority of previous studies have primarily focused on populations in Europe or the United States, potentially limiting the generalizability of the findings to other global regions. The NUTPOOL project aims to address these gaps by conducting an extensive individual participant data (IPD) meta-analysis. This study will evaluate the association between total and specific types of nut consumption and the future risk of NCDs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Type-2 diabetes incidence
Timeframe: Minimum of five years of median follow-up
CVD incidence
Timeframe: Minimum of five years of median follow-up
Coronary health disesase incidence
Timeframe: Minimum of five years of median follow-up
Stroke incidence
Timeframe: Minimum of five years of median follow-up
Total cancer incidence
Timeframe: Minimum of five years of median follow-up
All-cause mortality rate
Timeframe: Minimum of five years of median follow-up
CVD-mortality rate,
Timeframe: Minimum of five years of median follow-up
Cancer-mortality rate
Timeframe: Minimum of five years of median follow-up